1. Home
  2. BIAF vs RAYA Comparison

BIAF vs RAYA Comparison

Compare BIAF & RAYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIAF
  • RAYA
  • Stock Information
  • Founded
  • BIAF 2014
  • RAYA 2019
  • Country
  • BIAF United States
  • RAYA China
  • Employees
  • BIAF N/A
  • RAYA N/A
  • Industry
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • RAYA Metal Fabrications
  • Sector
  • BIAF Health Care
  • RAYA Consumer Discretionary
  • Exchange
  • BIAF Nasdaq
  • RAYA Nasdaq
  • Market Cap
  • BIAF 7.6M
  • RAYA 6.1M
  • IPO Year
  • BIAF 2022
  • RAYA 2022
  • Fundamental
  • Price
  • BIAF $0.16
  • RAYA $0.05
  • Analyst Decision
  • BIAF Hold
  • RAYA
  • Analyst Count
  • BIAF 1
  • RAYA 0
  • Target Price
  • BIAF N/A
  • RAYA N/A
  • AVG Volume (30 Days)
  • BIAF 12.0M
  • RAYA 63.9M
  • Earning Date
  • BIAF 11-13-2025
  • RAYA 01-01-0001
  • Dividend Yield
  • BIAF N/A
  • RAYA N/A
  • EPS Growth
  • BIAF N/A
  • RAYA N/A
  • EPS
  • BIAF N/A
  • RAYA N/A
  • Revenue
  • BIAF $7,681,059.00
  • RAYA $30,300,360.00
  • Revenue This Year
  • BIAF N/A
  • RAYA $20.95
  • Revenue Next Year
  • BIAF $20.04
  • RAYA N/A
  • P/E Ratio
  • BIAF N/A
  • RAYA N/A
  • Revenue Growth
  • BIAF 4.99
  • RAYA 49.10
  • 52 Week Low
  • BIAF $0.16
  • RAYA $0.03
  • 52 Week High
  • BIAF $2.26
  • RAYA $3.35
  • Technical
  • Relative Strength Index (RSI)
  • BIAF 34.12
  • RAYA 29.65
  • Support Level
  • BIAF $0.24
  • RAYA $0.04
  • Resistance Level
  • BIAF $0.45
  • RAYA $0.05
  • Average True Range (ATR)
  • BIAF 0.03
  • RAYA 0.01
  • MACD
  • BIAF -0.01
  • RAYA 0.04
  • Stochastic Oscillator
  • BIAF 7.50
  • RAYA 67.22

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

About RAYA Erayak Power Solution Group Inc.

Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from four products namely inverters, chargers, power bank, and gasoline generators. The company generates the majority of its revenue from Inverters. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.

Share on Social Networks: